ELISA

Overview

Enzyme-linked immunosorbent assay (ELISA) is a plate-based immunoassay for detecting and quantifying antibodies, antigens, or proteins in solution. In dengue research, ELISA is used broadly for: (1) measuring specific anti-viral antibody titres (anti-NS1, anti-E IgM/IgG); (2) measuring autoantibody levels against host proteins (anti-PDI, anti-HSP60, anti-vimentin, anti-platelet); and (3) quantifying viral antigens such as NS1 in clinical samples. For dengue-specific serology applications (IgM/IgG classification, NS1 antigen detection), see the specialised pages IgM-IgG Serology ELISA and NS1 Antigen Detection.

Key Points from Literature

Autoantibody quantification in dengue (Cheng2015)

Cheng2015 - NS1 P311-330 Anti-PDI Autoantibodies in DHF used ELISA to quantify anti-PDI, anti-HSP60, anti-vimentin, anti-NS1, and anti-P311–330 IgM and IgG in Vietnamese DHF/DF patient sera. Protocol: 1:25 serum dilution; HRP-conjugated secondary anti-human IgM/IgG; TMB or ABTS substrate; optical density read at 450 nm (TMB) or 405 nm (ABTS). Statistical analysis used linear mixed models (SAS PROC MIXED) to correct for intra-individual correlation in serial serum samples. All autoantibody targets were significantly elevated in DHF vs. normal controls; anti-P311–330 IgM was also significantly elevated in DHF vs. DF, distinguishing disease severity.

Contradictions & Debates

None yet recorded.

Sources